Registry of Aortic Valve Bioprostheses Established by Catheter
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The aim of this registry is to evaluate the overall survival up to 10 years of patients with aortic valve bioprostheses implanted via the transarterial or transapical route. Data from the register is enhanced by matching it with continuous data in the SNDS. Mandated by the French health authorities, this registry must be maintained as part of the management of any patient undergoing transarterial or transapical aortic valve bioprosthesis implantation. Participation in the registry is offered to all subjects eligible for bioprosthesis implantation.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
Locations
Other Locations
France
CHU Rennes - Pontchaillou
RECRUITING
Rennes
Contact Information
Primary
Martine GILARD
francetavi@sfcardio.fr
33(1) 44 90 70 28
Time Frame
Start Date: 2013-02
Estimated Completion Date: 2034-02
Participants
Target number of participants: 5000
Treatments
Transcatheter Aortic Valve Implantation
FRANCE TAVI registry aims to identify all patients with a change of valves implanted catheter meets the selection criteria of the technical accepting the scheduled evaluations in the context of this disease and who have agreed to participate in the study .
Authors
Related Therapeutic Areas
Sponsors
Leads: French Cardiology Society